Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (2936)	11/21/1997 7:09:00 PM
From: ALL	Read Replies (1) \| Respond to of 6136

Dr. Oliver, I have a basic question on options. When I read the CBOE option tables, I can't determine whether puts have been written or purchased. In the case of AGPH Dec 40 Puts, what would indicate whether the 4,071 puts were/are long or short? Thanks

To: Oliver & Co who wrote (2936)	12/3/1997 2:35:00 AM
From: Barron Von Hymen	Read Replies (2) \| Respond to of 6136

<<Someone bought today over 4,000 Dec $40 puts>>. If this was purely put buying, that seems to be a extremely high risk trade with not a great reward for such risk. Of course assuming, pure speculation with no inside information, but even inside information sometimes blows up if options expires before your "inside" news becomes public knowledge. Buying the puts, risked approx. $1.2 million that could have went to zero to make 2.8 mill. Could have made the same amount by shorting 312,000 shares, and more safer, because you don't have to worry about expiration within a few weeks as long as the stock didn't explode $10 higher that's less likely. But definitely begs of an investigation, eh ?